Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulsed oral sirolimus in autosomal dominant polycystic kidney disease
2012-000550-60Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in autosomal dominant polycystic kidney disease (ADPKD) comparing Pulsed oral sirolimus with Placebo (2 arms). Started Nov 2013; status: completed.
02
Drugs
sirolimus
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on 2012-000550-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000550-60.